Owings Mills, MD, United States of America

Christopher M Coleman

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Christopher M Coleman

Introduction

Christopher M Coleman, an accomplished inventor based in Owings Mills, Maryland, has made significant contributions to the field of vaccine development. With two patents to his name, Coleman focuses on advancing medical science through innovative solutions aimed at combating infectious diseases.

Latest Patents

Among Coleman's latest patents is a groundbreaking development in the realm of multivalent vaccines for rabies virus and coronaviruses. This innovative vaccine provides methods and compositions designed to induce an immune response that confers dual protection against infections by either or both the rabies virus and coronaviruses. The patent includes therapeutic applications for existing infections, targeting symptoms and neutralizing the infecting agents. Specifically, it features a recombinant rabies virus vector that encodes a nucleotide sequence for at least one immunogenic glycoprotein fragment of coronaviruses, along with pharmaceutical compositions utilizing these vaccine vectors.

Career Highlights

Coleman's professional journey includes pivotal roles at prestigious organizations such as Thomas Jefferson University and the U.S. Department of Health and Human Services. His work focuses on leveraging cutting-edge biotechnologies to develop innovative medical interventions, showcasing his commitment to public health and safety.

Collaborations

Throughout his career, Coleman has collaborated with eminent scientists, including Reed F Johnson and Matthias Johannes Schnell. These partnerships have fostered a collaborative spirit in research and innovation, allowing for the exchange of ideas and expertise that contributes to the advancement of medical science.

Conclusion

Christopher M Coleman stands out as a visionary inventor who combines his expertise with innovative thinking to address pressing health challenges. His work in developing multivalent vaccines is a testament to his dedication to enhancing medical interventions and improving public health outcomes. As he continues to innovate and collaborate, his contributions are likely to resonate in the field of infectious disease prevention and treatment for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…